Under this guidance, the FDA does not intend to regulate low-risk general wellness products - including self-reported tracking platforms that promote healthy lifestyle behaviors like protein intake, resistance training, and hydration - as medical devices, provided they make no diagnostic or disease-treatment claims
## Side Effect Comparison: What the Trials Report All GLP-1 medications share a similar side effect profile centered on gastrointestinal symptoms
188 HSP90 as a master regulator of oncogenic signaling networks HSP90 is frequently overexpressed in cancers such as cholangiocarcinoma, lung cancer, gastric cancer, breast cancer, and glioblastoma, and its elevated levels are often associated with poor prognosis
The long-term dose of Saxenda is almost double the highest dose of Victoza
Diabetes status: Patients with Type 2 diabetes typically lose about 10% versus 15% for non-diabetic patients